|
| 37016669 | Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection. | medRxiv | 2024 |
| 36327388 | Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022. | Clin Infect Dis | 2023 |
| 37917142 | Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. | Emerg Infect Dis | 2023 |
| 37662226 | SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis. | medRxiv | 2023 |
| 37796753 | Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged â¿¥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37790578 | Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022. | medRxiv | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 37425863 | Design and Analysis Heterogeneity in Observational Studies of COVID-19 Booster Effectiveness: A Review and Case Study. | medRxiv | 2023 |
| 37255285 | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. | Clin Infect Dis | 2023 |
| 37246148 | Risk factors for infection with influenza A(H3N2) virus on a US university campus, October-November 2021. | Influenza Other Respir Viruses | 2023 |
| 37246146 | Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. | Influenza Other Respir Viruses | 2023 |
| 37104244 | Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023. | MMWR Morb Mortal Wkly Rep | 2023 |
| 37337047 | Immune response to COVID-19 vaccination in a population with a history of elevated exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water. | J Expo Sci Environ Epidemiol | 2023 |
| 37301704 | Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report-IVY Network, February 1-August 31, 2022. | Vaccine | 2023 |
| 37127782 | A rapid and flexible microneutralization assay for serological assessment of influenza viruses. | Influenza Other Respir Viruses | 2023 |
| 36960655 | Influenza Vaccine Effectiveness Among Children: 2011-2020. | Pediatrics | 2023 |
| 36754289 | The impact of bedside wipes in multi-patient rooms: a prospective, crossover trial evaluating infections and survival. | J Hosp Infect | 2023 |
| 36883903 | Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants. | J Infect Dis | 2023 |
| 36854108 | Comparing the Etiology of Viral Acute Respiratory Illnesses Between Children Who Do and Do Not Attend Childcare. | Pediatr Infect Dis J | 2023 |
| 36694363 | Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study. | Clin Infect Dis | 2023 |
| 36650162 | Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants. | Nat Commun | 2023 |
| 36875204 | Respiratory virus circulation during the first year of the COVID-19 pandemic in the Household Influenza Vaccine Evaluation (HIVE) cohort. | Influenza Other Respir Viruses | 2023 |
| 36909298 | K-medoids clustering of hospital admission characteristics to classify severity of influenza virus infection. | Influenza Other Respir Viruses | 2023 |
| 36504336 | Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. | Clin Infect Dis | 2023 |
| 36599411 | Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020. | Emerg Infect Dis | 2023 |
| 32693853 | Using the MCRISP Network for Surveillance of Pediatric Exanthema in Child Care Centers. | Disaster Med Public Health Prep | 2022 |
| 35710506 | Vaccine-associated attenuation of subjective severity among outpatients with influenza. | Vaccine | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 35798681 | The variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021. | J Med Virol | 2022 |
| 35818721 | Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectiveness. | Influenza Other Respir Viruses | 2022 |
| 35684961 | Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza. | Clin Infect Dis | 2022 |
| 35385875 | mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients. | J Infect Dis | 2022 |
| 35588275 | The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade. | J Virol | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36580424 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged â¿¥65 Years - IVY Network, 18 States, September 8-November 30, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36424890 | SARS-CoV-2 Vaccine Strain Selection: Guidance From Influenza. | J Infect Dis | 2022 |
| 36523413 | Respiratory Virus Circulation during the First Year of the COVID-19 Pandemic in the Household Influenza Vaccine Evaluation (HIVE) Cohort. | medRxiv | 2022 |
| 36264830 | Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36379754 | Burden of medically attended influenza infection and cases averted by vaccination - United States, 2016/17 through 2018/19 influenza seasons. | Vaccine | 2022 |
| 36263068 | Rapid transmission and tight bottlenecks constrain the evolution of highly transmissible SARS-CoV-2 variants. | bioRxiv | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36384703 | Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. | Eur Respir Rev | 2022 |
| 36374708 | Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States. | Vaccine | 2022 |
| 35271561 | Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 35170231 | Vaccine effectiveness against COVID-19 among symptomatic persons aged â¿¥12 years with reported contact with COVID-19 cases, February-September 2021. | Influenza Other Respir Viruses | 2022 |
| 35324878 | Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34674220 | Environmental contamination with SARS-CoV-2 in nursing homes. | J Am Geriatr Soc | 2022 |